Fisher & Paykel Healthcare Corporation Limited

NZSE FPH.NZ

Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2024: USD 220.10 M

Fisher & Paykel Healthcare Corporation Limited EBITDA is USD 220.10 M for the year ending March 31, 2024, a -18.83% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2023 was USD 271.17 M, a -35.35% change year over year.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2022 was USD 419.42 M, a -25.69% change year over year.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2021 was USD 564.42 M, a 117.48% change year over year.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2020 was USD 259.53 M, a 8.44% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NZSE: FPH.NZ

Fisher & Paykel Healthcare Corporation Limited

CEO Mr. Lewis G. Gradon
IPO Date Jan. 1, 2000
Location New Zealand
Headquarters 15 Maurice Paykel Place
Employees 6,978
Sector Health Care
Industries
Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Similar companies

CEN.NZ

Contact Energy Limited

USD 5.17

-0.94%

RYM.NZ

Ryman Healthcare Limited

USD 2.51

0.12%

FBU.NZ

Fletcher Building Limited

USD 1.60

2.14%

ATM.NZ

The a2 Milk Company Limited

USD 3.45

2.17%

MFT.NZ

Mainfreight Limited

USD 40.05

0.23%

StockViz Staff

January 15, 2025

Any question? Send us an email